泛亚电竞官方版 - Home - Precision Cancer Medicine

V体育ios版 - Precision Cancer Medicine 2024 CiteScore Released: 2.1

We are pleased to announce that the Precision Cancer Medicine (PCM) has achieved its 2024 CiteScore: 2. 1 VSports. PCM ranks as follows across various categories: 269 out of 568 in Surgery, 275 out of 415 in Oncology, 14 out of 22 in Oncology (nursing), 183 out of 233 in Cancer Research, 179 out of 275 in Pharmacology (medical) and 69 out of 139 in Anesthesiology and Pain Medicine. This milestone underscores our ongoing commitment to publishing impactful research in the field.

How to Detect and Treat NSCLC Patients with Oncogenic Fusions

The series on “How to Detect and Treat NSCLC Patients with Oncogenic Fusions” was edited by Drs Fabrizio Tabbò (University of Turin, Italy), Umberto Malapelle (University of Naples Federico II, Italy), Maria Lucia Reale (University of Turin, Italy), Angela Listì (University of Turin, Italy).

"V体育官网" ALK and ROS-1 NSCLC Patients Treatment Approach Based on Genomic Profile by Liquid Biopsy

ALK and ROS-1 tyrosine kinase inhibitors (TKIs) have become the new standard of care in the first-line treatment of advanced ALK and ROS-1 positive NSCLC patients. As there are several TKIs, upon progression, the optimal sequential ALK and ROS-1 TKI strategy at progression is relevant, and this may have an impact on patients' outcome V体育官网. Mechanisms of acquired resistance knowledge will be also relevant to develop new personalized treatment strategies to overcome in the near future. .

Eastern and Western Perspectives on Precision Cancer Medicine

The series on “Eastern and Western Perspectives on Precision Cancer Medicine” was edited by Drs Zhi-Ming Shao and Xiao-Mao Guo, Fudan University Shanghai Cancer Center, Shanghai, China.

Quality Assurance in Radiotherapy

This series on “Quality Assurance in Radiotherapy” is edited by Dr. Paul Van Houtte and Dr. Dirk Van Gestel V体育安卓版. The authors are proud to provide a comprehensive review and further discussion on quality assurance in radiotherapy, and include empirical experience and valuable opinions from recognized experts in this field from prestigious institutions of different countries.

Precision Oncology Tumor Board

Guest Editor: Balazs Halmos, MD
Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA

The Precision Oncology Tumor Board is to provide a global forum for dialogue and education for discussion about the optimal use of biomarker testing in a vast number of emerging clinical settings. An article for this column could be a Case-Based Review, providing a case with educational values and relevant review of the literature and highlighting the level of evidence supporting key decisions. The format of this category is recommended as follows: Introduction, Case Presentation, Tumor Management, Case-related Literature Review and Conclusion. Specific guidelines of this series could be found in the Author Instructions. VSports最新版本.

‹ ›

Cover image by Prof. Yanhui Xu More >>

Articles in Press

Past Issues

About pcm

Manuscript Submission

AME Editing Service

Reprint & Permission

Advertising (V体育ios版)

Contact us

General editorial enquiries:
Email: pcm@www.qiuluzeuv.cn (V体育官网)
Copyright related contact:
Email: permissions@www.qiuluzeuv.cn
Commercial Sales contact (Reprints, advertising, etc.):
Email: sales@www.qiuluzeuv.cn

Review Article

Current and future perspectives in clinical practice in KRAS-mutated non-small cell lung cancer: a literature review

Alejandro Olivares-Hernández, Luis Posado-Domínguez, María Martín-Galache, Juan Carlos Redondo-González, Jonnathan Roldán-Ruiz, Lorena Bellido-Hernández, Emilio Fonseca-Sánchez, Edel del Barco-Morillo

Precision Cancer Medicine

2025;

(30 May 2025)

PDF Full Text (1626) Reporting Checklist Peer Review File COI Form Open Access

Original Article

Evaluation of the anti-tumor activity of histone deacetylase inhibitors (HDAC6) on human pancreatic adenocarcinoma (PANC-1) cell line using a zebrafish xenograft model

Mays Helmi

Precision Cancer Medicine

2024;

(30 September 2024)

PDF Full Text (1262) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Case Report

Safe management of 5-fluorouracil, leucovorin, and oxaliplatin (FOLFOX) + panitumumab in a patient with metastatic colorectal cancer undergoing hemodialysis for bilateral nephrectomy: a case report

Elisabetta Filoni, Vittoria Musci, Giacomo Dibisceglia, Francesco Mannavola

Precision Cancer Medicine

2024;

(30 September 2024)

PDF Full Text (3488) Reporting Checklist Peer Review File COI Form Open Access

Review Article

NTRK1/2/3: biology, detection and therapy

Maristella Bungaro, Edoardo Garbo

Precision Cancer Medicine

2024;

(30 September 2024)

PDF Full Text (3256) Peer Review File COI Form Open Access

Review Article

ALK fusions turn sixteen in lung cancer: a review on their biology, detection and therapy

Francesco Facchinetti, Laura Gandolfi, Damien Vasseur, Laura Melocchi, Seshiru Nakazawa, Marcello Tiseo, Luc Friboulet, Giulio Rossi

Precision Cancer Medicine

2024;

(30 September 2024)

PDF Full Text (3199) Peer Review File COI Form Open Access

Review Article

Genetic and non-genetic resistance mechanisms in non-small cell lung cancer harboring (non-ALK) oncogenic fusions

Marco Sposito, Ilaria Mariangela Scaglione, Alessandra Dodi, Alice Avancini, Ilaria Trestini, Daniela Tregnago, Jessica Insolda, Michele Milella, Sara Pilotto, Lorenzo Belluomini

Precision Cancer Medicine

2024;

(30 September 2024)

PDF Full Text (2044) Peer Review File COI Form Open Access

Editorial Commentary

Quality assurance in thoracic oncology: the surgeon’s perspective

Paraskevas Lyberis, Federico Femia, Enrico Ruffini

Precision Cancer Medicine

2023;

(30 June 2023)

PDF Full Text (2074) Peer Review File COI Form Open Access

Case Report

Locally advanced HPV-positive oropharyngeal cancer cured with single agent pembrolizumab in a patient using cannabis: a case report

Azamat Abdyraimov, Nikita Karpovich, Lesia Tkachuk, Karine Darbinyan

Precision Cancer Medicine

2023;

(30 June 2023)

PDF Full Text (4268) Reporting Checklist Peer Review File COI Form Open Access

Case Report

A challenge in emergency department: a case report of oxaliplatin-induced Kounis syndrome

Marcello Albanesi, Raffaele Didonna, Nada Chaoul, Federica Mazzone, Marco Zurlo, Fortunato Iacovelli, Francesco Monitillo, Flavio Rimmaudo, Marco Tucci, Mauro Cives, Camillo Porta, Vito Procacci

Precision Cancer Medicine

2023;

(30 June 2023)

PDF Full Text (2487) Reporting Checklist Peer Review File COI Form Open Access

Case Report

A case report of EGFR L861Q mutation in synchronous de novo small cell and non-small cell lung cancer: molecular interrogation identifies origin and potential options for targeted therapy

Adam M. Hines, Sunita Patruni, Nidhi Kataria, Jeff Boyd, Nagashree Seetharamu, Daniel A. King

Precision Cancer Medicine

2023;

(30 June 2023)

PDF Full Text (3393) Reporting Checklist Peer Review File COI Form Open Access

Case Report

Pathologically documented brain necrosis: response to bevacizumab after irradiation for solitary fibrous tumour/haemangiopericytoma: case report and literature review

Michael J. McKay, Hassan Zadeh, Richard Foster, Monica Dumbrava

Precision Cancer Medicine

2023;

(30 June 2023)

PDF Full Text (2460) Reporting Checklist Peer Review File COI Form Open Access

Review Article

NRG1 fusions in non-small cell lung cancer: a narrative review on biology, detection and therapy

Lucia Anna Muscarella

Precision Cancer Medicine

2023;

(30 June 2023)

PDF Full Text (8920) Reporting Checklist COI Form Open Access

Review Article

Microsatellite instability and immunotherapy in gastric cancer: a narrative review

Yantao Duan, Dazhi Xu

Precision Cancer Medicine

2023;

(30 June 2023)

PDF Full Text (14957) Reporting Checklist Peer Review File COI Form Open Access

Review Article

Extracellular vesicles long RNA for cancer diagnosis and prognosis: a narrative review

Jinying Chen, Shenglin Huang

Precision Cancer Medicine

2023;

(30 June 2023)

PDF Full Text (3165) Reporting Checklist Peer Review File COI Form Open Access

Editorial

A quality assurance program: a clear necessity in modern oncology care

Paul Van Houtte, Dirk Van Gestel

Precision Cancer Medicine

2023;

(30 June 2023)

PDF Full Text (1819) COI Form Open Access

Editorial

Choice of first-line anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor (TKI) based on the results of a systematic review and network meta-analysis

Edyta Maria Urbanska

Precision Cancer Medicine

2023;

(30 June 2023)

PDF Full Text (2265) COI Form Open Access

Case Report

The role of concurrent amplification of PD-L1, PD-L2 and JAK2 in metastatic lung adenocarcinoma as a biomarker of immune checkpoint inhibitor response: a case report

William J. Phillips, Arif Awan, Bryan Lo, Andrea Redway, Garth Nicholas

Precision Cancer Medicine

2023;

(30 March 2023)

PDF Full Text (4554) Reporting Checklist COI Form Open Access

Case Report

Endoscopic endonasal removal of nasal cavity chondrosarcoma extending to the base of the skull: a case report

Nikita I. Mikhailov, Anton M. Zaitsev, Andrew G. Rerberg, Sergei A. Kisarev, Gennadei I. Khokhrikov, Artem E. Lazarev, Olga N. Kirsanova, Tatyana M. Kobyletskaya, Tatiana S. Bezbabicheva, Angelina V. Krivobokova, Peter V. Shegay, Andrey D. Kaprin

Precision Cancer Medicine

2023;

(30 March 2023)

PDF Full Text (2804) Reporting Checklist Peer Review File COI Form Open Access

Review Article

Radiotherapy in non-surgical management of esophageal cancer in the era of immuno-oncology: a narrative review

Hongcheng Zhu, Jingyi Shen, Mohamed Emam Sobeih, Xinmin Zhao, Huijun Zhu, Kuaile Zhao

Precision Cancer Medicine

2023;

(30 March 2023)

PDF Full Text (3479) Reporting Checklist COI Form Open Access

Review Article

The use of ¹⁸F-FDG PET/CT for radiotherapy treatment planning in non-small cell lung cancer: a mini-review

Eleni Gkika, Anca L. Grosu, Ursula Nestle

Precision Cancer Medicine

2023;

(30 March 2023)

PDF Full Text (4228) COI Form Open Access

View more articles

Currently no content available!

Original Article

Comparison of cancer incidence and mortality between China and the United States

Zezhou Wang, Changming Zhou, Xiaoshuang Feng, Miao Mo, Jie Shen, Ying Zheng

Published online: 30 December 2021

PDF Full Text (24133) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Review Article

Role of radiation therapy in triple negative breast cancer: current state and future directions—a narrative review

Fares Azoury, Shagun Misra, Aisling Barry, Joelle Helou

Published online: 30 March 2022

PDF Full Text (19649) Reporting Checklist COI Form Chinese (4336) Open Access

Review Article

Non-small cell lung cancer PDL1 >50%—should we go single or combo?

Waleed Kian, Laila C. Roisman, Dina Levitas, Nadav Wallach, Adam Abo-Sharb, Aharon Y. Cohen, Alexander Yakobson, Nir Peled, Yulia Dudnik

Published online: 15 March 2020

PDF Full Text (15127) COI Form Open Access

Review Article

Microsatellite instability and immunotherapy in gastric cancer: a narrative review

Yantao Duan, Dazhi Xu

Published online: 30 May 2023

PDF Full Text (14957) Reporting Checklist Peer Review File COI Form Open Access

Review Article: Precision Oncology Tumor Board

Precision medicine: BRAF mutations in thyroid cancer

Amanda Podolski, Enrico Castellucci, Balazs Halmos

Published online: 22 November 2019

PDF Full Text (13563) COI Form Chinese (3935) Open Access

Case Report: Precision Oncology Tumor Board

Cases of ROS1-rearranged lung cancer: when to use crizotinib, entrectinib, lorlatinib, and beyond?

Kartik Sehgal, Andrew J. Piper-Vallillo, Hollis Viray, Adeel M. Khan, Deepa Rangachari, Daniel B. Costa

Published online: 15 June 2020

PDF Full Text (11938) COI Form Open Access

Review Article

The structure of mTOR complexes at a glance

Huirong Yang, Xizi Chen, Mengjie Liu, Yanhui Xu

Published online: 03 August 2018

PDF Full Text (11437) COI Form Open Access

Review Article

NTRK and NRG1 gene fusions in advanced non-small cell lung cancer (NSCLC)

Alessandro Russo, Ana Rita Lopes, Katherine Scilla, Ranee Mehra, Vincenzo Adamo, Julio Oliveira, Stephen V. Liu, Christian Rolfo

Published online: 15 June 2020

PDF Full Text (11027) COI Form Chinese (3094) Open Access

Review Article

A narrative review of BRAF alterations in human tumors: diagnostic and predictive implications

Lynette M. Sholl

Published online: 30 December 2020

PDF Full Text (10761) Reporting Checklist COI Form Chinese (10456) Open Access

Review Article

Alternative non-homologous end joining repair: a master regulator of genomic instability in cancer

Daniele Caracciolo, Martina Montesano, Pierosandro Tagliaferri, Pierfrancesco Tassone

Published online: 08 March 2019

PDF Full Text (10620) COI Form Chinese (3982) Open Access

Review Article

Non-small cell lung cancer targetable mutations: present and future

Peter Vu, Sandip Pravin Patel

Published online: 15 March 2020

PDF Full Text (10286) COI Form Chinese (8051) Open Access

Review Article

A narrative review of microRNA therapeutics: understanding the future of microRNA research

Linhui Liang, Xianghuo He

Published online: 30 December 2021

PDF Full Text (10027) Reporting Checklist Peer Review File COI Form Open Access

Editorial

Diffuse large B-cell lymphoma with molecular variations more than ABC and GCB classification

Yi Miao, L. Jeffrey Medeiros, Jianyong Li, Ken H. Young

Published online: 06 July 2018

PDF Full Text (9916) COI Form Open Access

Case Report

Giant perivascular spaces in brain: case report with a comprehensive literature review

Gaurav Cheraya, Suryansh Bajaj, Salil Sharma, Darshan Gandhi, Jignesh Shah, Nisarg Parikh, Nishant Gupta

Published online: 30 September 2022

PDF Full Text (9708) Reporting Checklist Peer Review File COI Form Open Access

Review Article

NRG1 fusions in non-small cell lung cancer: a narrative review on biology, detection and therapy

Lucia Anna Muscarella

Published online: 14 June 2023

PDF Full Text (8920) Reporting Checklist COI Form Open Access

Review Article

The past, present, and future of non-metastatic castration-resistant prostate cancer (nmCRPC): a narrative review

Natalia Vidal, Juan Gómez Rivas, Laura Fernández, Jesús Moreno, Javier Puente

Published online: 30 June 2022

PDF Full Text (8664) Reporting Checklist Peer Review File COI Form Chinese (7195) Open Access

Review Article

ROS-1 NSCLC therapy resistance mechanism

Miguel García-Pardo, Antonio Calles

Published online: 30 June 2021

PDF Full Text (8121) COI Form Open Access

Editorial Commentary

PARP inhibitors beyond BRCA-mutated cancers: precision medicine at the crossroads

Bartłomiej Tomasik, Michał Bieńkowski, Jacek Jassem

Published online: 30 June 2021

PDF Full Text (8121) COI Form Open Access

Review Article

ROS1 non-small cell lung cancer patients treatment approach

Laura Moliner, Edurne Arriola

Published online: 30 September 2021

PDF Full Text (7830) COI Form Open Access

Review Article

A narrative review of chemotherapy in advanced triple negative breast cancer

Maria L. Romero Lagunes, Rossanna C. Pezo

Published online: 30 June 2021

PDF Full Text (7585) Reporting Checklist COI Form Open Access

Full Most Read article list >>

Editorial

AR-V7 and treatment selection in advanced prostate cancer: are we there yet?

Diogo A. Bastos, Emmanuel S. Antonarakis

Case Report: Precision Oncology Tumor Board

Cases of ROS1-rearranged lung cancer: when to use crizotinib, entrectinib, lorlatinib, and beyond?

Kartik Sehgal, Andrew J. Piper-Vallillo, Hollis Viray, Adeel M. Khan, Deepa Rangachari, Daniel B. Costa

Journal highlight more

Precision Cancer Medicine is an open access, peer-reviewed online journal dedicated to precise diagnosis and targeted treatment of cancers and personalized care for patients, encompassing areas of oncology, pathology, imaging, radiotherapy, chemotherapy, surgery, anesthesiology, nursing and etc.